Log in
Enquire now
Verge Genomics

Verge Genomics

Verge Genomics is a company focused on the discovery and development of drugs for the treatment of neurodegenerative diseases with the use of machine learning and computational genomics.

OverviewStructured DataIssuesContributors

Contents

vergegenomics.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Parkinson's disease
Parkinson's disease
Neuroscience
Neuroscience
Drug discovery
Drug discovery
Genomics
Genomics
Biomedical engineering
Biomedical engineering
Bioinformatics
Bioinformatics
Biopharmaceutical
Biopharmaceutical
...
Location
United States
United States
San Francisco
San Francisco
South San Francisco, California
South San Francisco, California
B2X
B2B
B2B
0
CEO
Alice Zhang
Alice Zhang
Founder
Alice Zhang
Alice Zhang
0
Jason Chen
Jason Chen
0
AngelList URL
angel.co/verge-genomics
Pitchbook URL
pitchbook.com/profiles...120581-74
Accelerator
Y Combinator
Y Combinator
0
Accelerator Batch
‌
Y Combinator S15 Batch
0
Number of Employees (Ranges)
51 – 2000
Full Address
2 Tower Place, South San Francisco, CA 94080, US
Investors
Threshold Ventures
Threshold Ventures
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund
WuXi AppTec
WuXi AppTec
LifeForce Capital
LifeForce Capital
ALS Investment Fund
ALS Investment Fund
Agent Capital
Agent Capital
‌
Y Combinator W19 Batch
Eli Lilly
Eli Lilly
...
Founded Date
2015
0
Total Funding Amount (USD)
134,120,000
Latest Funding Round Date
December 16, 2021
Competitors
Shivom
Shivom
Glassdoor ID
2364082
Latest Funding Type
Series B
Series B
Wellfound ID
verge-genomics
Country
United States
United States

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
98,000,000
Y Combinator URL
ycombinator.com/compani...genomics0

Verge Genomics is a company that develops a drug discovery platform for neurodegenerative diseases. It was founded in 2015 by Alice Zhang and Jason Chen. Verge Genomics has received funding from OS Fund, WuXi AppTec, and ALS Investment Fund. The company is headquartered in San Francisco, California, United States.

Products and services

Verge Genomics's computational biology and artificial intelligence platform is able to generate novel drug compounds to target genes involved in neurodegenerative diseases. The platform is designed to construct new therapeutics for diseases that are caused by multiple gene anomalies. The company uses datasets collected from human tissue samples of patients with diseases such as Parkinson's and amyotrophic lateral sclerosis (ALS). Several new therapeutics for ALS developed by Verge Genomics have passed preclinical trials.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Verge Genomics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.